Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
EXTON, PA, April 10, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists are currently managing the condition—and where emerging therapies may soon fit in. According to the recently published and 2025 update of Patient Chart Dynamix™: Systemic Lupus Erythematosus (US) , four in ten systemic lupus erythematosus (SLE) patients also carry a CLE diagnosis, with dermatologic involvement playing a critical role in therapeutic decision-making. When cutaneous features such as malar rash, discoid lesions, and photosensitivity are present, rheumatologists are more likely to turn to biologics, most notably AstraZeneca's Saphnelo (anifrolumab), in pursuit of more targeted disease control. In fact, among SLE patients with skin involvement, Saphnelo is now favored over Benlysta in a growing number of cases?. These trends are also reflected in the broader CLE treatment la
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union [Yahoo! Finance]Yahoo! Finance
- Nine of the largest pharma companies ink deals with Trump to lower drug prices [CNBC]CNBC
- Digital Manufacturing in Life Sciences Market to Reach USD 177.5 Billion by 2035, Leading at 15.6% CAGR by 2035 [Yahoo! Finance]Yahoo! Finance
- Several top drugmakers to lower US prices for some drugs-sources [Yahoo! Finance]Yahoo! Finance
- This is how exposed European Big Pharma is to the U.S. [CNBC]CNBC
AZN
Sec Filings
- 12/19/25 - Form 6-K
- 12/16/25 - Form 6-K
- 12/16/25 - Form 6-K
- AZN's page on the SEC website